18 and older, any sex, with Tinnitus. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Tinnitus Functional Index (TFI); Measure of Tinnitus DistressPrimary· T0: Baseline, T1: Post-intervention 1 (after both group complete initial intervention), T2: Post-intervention 2 (after R-ICBT group complete Full ICBT), T3: 2-months post-intervention
Tinnitus Functional Index (TFI) is a 25-item questionnaire that evaluates the severity of tinnitus distress. Total possible score ranges from 0-to-100 with higher scores suggesting more severe tinnitus distress (i.e., worse outcome). Scores \>25 indicate tinnitus is a significant problem requiring tinnitus intervention.
T0: Baseline
Group
Value
95% CI
R-ICBT
48.7
± 25.51
F-ICBT
50.52
± 26.65
T1: Post-intervention 1
Group
Value
95% CI
R-ICBT
32.13
± 21.38
F-ICBT
28.95
± 20.75
T2: Post-intervention 2 (both completed full ICBT)
Group
Value
95% CI
R-ICBT
30.66
± 23.45
F-ICBT
28.95
± 20.75
T3: 2-month post-intervention
Group
Value
95% CI
R-ICBT
23.81
± 9.87
F-ICBT
27.16
± 20.78
Tinnitus Cognition Questionnaire (TCQ); Measure of Tinnitus CognitionSecondary· T0: Baseline, T1: Post-intervention 1 (after both group complete initial intervention), T2: Post-intervention 2 (after R-ICBT group complete Full ICBT), T3: 2-months post-intervention
Tinnitus Cognition Questionnaire (TCQ) is a 26-item questionnaire that assesses positive and negative cognitions associated with tinnitus. The first 13 items refer to negative thoughts and the second 13 items refer to positive thoughts. Responses are marked on a five-point Likert scale (0 to 4). The negative items (1-13) are scored 0-4, whereas the positive items (14-26) are reverse-scored: 4-0. The scoring procedure involves the simple addition of the number circled by the respondent for items 1-13 and the addition of reverse-scored items 14-26. The total score of the TCQ has a potential rang
T0: Baseline
Group
Value
95% CI
R-ICBT
44.67
± 20.43
F-ICBT
42.52
± 18.58
T1: Post-intervention 1
Group
Value
95% CI
R-ICBT
30.96
± 20.03
F-ICBT
27.26
± 20.17
T2: Post-intervention 2 (both completed full ICBT)
Group
Value
95% CI
R-ICBT
28.93
± 17.81
F-ICBT
27.26
± 20.17
T3: 2-month post-intervention
Group
Value
95% CI
R-ICBT
25.30
± 15.84
F-ICBT
23.07
± 17.54
Patient Health Questionnaire (PHQ-9); Measure of DepressionSecondary· T0: Baseline, T1: Post-intervention 1 (after both group complete initial intervention), T2: Post-intervention 2 (after R-ICBT group complete Full ICBT), T3: 2-months post-intervention
Patient Health Questionnaire (PHQ-9) is a 9-item questionnaire that assesses depression severity. Responses are marked on a four-point Likert scale (0 to 3). The total score can range from 0 to 27 with higher scores indicating more severe depression (i.e., worse outcome).
T0: Baseline
Group
Value
95% CI
R-ICBT
9.17
± 7.12
F-ICBT
9.10
± 7.14
T1: Post-intervention 1
Group
Value
95% CI
R-ICBT
4.96
± 5.07
F-ICBT
4.32
± 3.95
T2: Post-intervention 2 (both completed full ICBT)
Group
Value
95% CI
R-ICBT
5.04
± 5.7
F-ICBT
4.32
± 3.95
T3: 2-month post-intervention
Group
Value
95% CI
R-ICBT
3.35
± 4.17
F-ICBT
4.12
± 4.4
Generalized Anxiety Disorder (GAD-7); Measure of AnxietySecondary· T0: Baseline, T1: Post-intervention 1 (after both group complete initial intervention), T2: Post-intervention 2 (after R-ICBT group complete Full ICBT), T3: 2-months post-intervention
Generalized Anxiety Disorder (GAD-7) is a 7-item questionnaire that assesses the severity of anxiety. Responses are marked on a four-point Likert scale (0 to 3). The total score can range from 0 to 21 with higher scores indicating more severe anxiety (i.e., worse outcome).
T0: Baseline
Group
Value
95% CI
R-ICBT
7.75
± 6.77
F-ICBT
9.19
± 6.39
T1: Post-intervention 1
Group
Value
95% CI
R-ICBT
5.21
± 5.62
F-ICBT
4.48
± 4.17
T2: Post-intervention 2 (both completed full ICBT)
Group
Value
95% CI
R-ICBT
4.86
± 5.84
F-ICBT
4.48
± 4.17
T3: 2-month post-intervention
Group
Value
95% CI
R-ICBT
3.70
± 3.88
F-ICBT
4.68
± 4.75
Insomnia Severity Index (ISI); Measure of InsomniaSecondary· T0: Baseline, T1: Post-intervention 1 (after both group complete initial intervention), T2: Post-intervention 2 (after R-ICBT group complete Full ICBT), T3: 2-months post-intervention
Insomnia Severity Index (ISI) is a 7-item questionnaire that evaluates insomnia. Responses are marked on a five-point Likert scale (0 to 4). The total score can range from 0 to 28 with higher scores indicating more severe insomnia (i.w., worse outcome).
T0: Baseline
Group
Value
95% CI
R-ICBT
11.90
± 7.45
F-ICBT
12.25
± 7.7
T1: Post-intervention 1
Group
Value
95% CI
R-ICBT
8.93
± 6.5
F-ICBT
7.46
± 5.8
T2: Post-intervention 2 (both completed full ICBT)
Group
Value
95% CI
R-ICBT
8.43
± 5.93
F-ICBT
7.46
± 5.8
T3: 2-month post-intervention
Group
Value
95% CI
R-ICBT
7.13
± 5
F-ICBT
6.33
± 6.08
EuroQol EQ-5D-5L VAS; Measure of Health-related Quality of LifeSecondary· T0: Baseline, T1: Post-intervention 1 (after both group complete initial intervention), T2: Post-intervention 2 (after R-ICBT group complete Full ICBT), T3: 2-months post-intervention
EQ-5D-5L VAS is a single-item questionnaire that evaluates the health-related quality of life. Responses are marked on a 0-100 scale with higher scores indicating higher health-related quality o life (i.e., better outcome).
T0: Baseline
Group
Value
95% CI
R-ICBT
72.59
± 17
F-ICBT
75.43
± 15.92
T1: Post-intervention 1
Group
Value
95% CI
R-ICBT
79.71
± 12.14
F-ICBT
78.15
± 17.51
T2: Post-intervention 2 (both completed full ICBT)
Group
Value
95% CI
R-ICBT
76.43
± 15.79
F-ICBT
78.15
± 17.51
T3: 2-month post-intervention
Group
Value
95% CI
R-ICBT
78.22
± 11.29
F-ICBT
85.87
± 6.91
Tinnitus and Hearing Survey (THS) - Tinnitus Sub-scale; Measure of Tinnitus ProblemSecondary· T0: Baseline, T1: Post-intervention 1 (after both group complete initial intervention), T2: Post-intervention 2 (after R-ICBT group complete Full ICBT), T3: 2-months post-intervention
Tinnitus and Hearing Survey (THS) is a 10-item questionnaire that helps in determining how much of a patient's complaint about tinnitus is due to a hearing problem and how much is due specifically to the tinnitus. THS has three sections/subscales (A, B, and C). Section A consists of four items that address common tinnitus problems. Section B contains four items that address hearing. Section C, which includes two items, which focus on sound tolerance problem and ability to participate in group therapy. Responses for each item can range from 0 (not a problem) to 4 (very big problem). The total T
T0: Baseline
Group
Value
95% CI
R-ICBT
5.79
± 4.55
F-ICBT
6.29
± 5.70
T1: Post-intervention 1
Group
Value
95% CI
R-ICBT
3.21
± 3.32
F-ICBT
2.85
± 2.66
T2: Post-intervention 2 (both completed full ICBT)
Group
Value
95% CI
R-ICBT
3.36
± 3.68
F-ICBT
2.85
± 2.66
T3: 2-month post-intervention
Group
Value
95% CI
R-ICBT
2.78
± 3.19
F-ICBT
2.07
± 2.12
Tinnitus and Hearing Survey (THS) - Hearing Sub-scale; Measure of Hearing ProblemSecondary· T0: Baseline, T1: Post-intervention 1 (after both group complete initial intervention), T2: Post-intervention 2 (after R-ICBT group complete Full ICBT), T3: 2-months post-intervention
Tinnitus and Hearing Survey (THS) is a 10-item questionnaire that helps in determining how much of a patient's complaint about tinnitus is due to a hearing problem and how much is due specifically to the tinnitus. THS has three sections/subscales (A, B, and C). Section A consists of four items that address common tinnitus problems. Section B contains four items that address hearing. Section C, which includes two items, which focus on sound tolerance problem and ability to participate in group therapy. Responses for each item can range from 0 (not a problem) to 4 (very big problem). The total T
T0: Baseline
Group
Value
95% CI
R-ICBT
6.19
± 4.84
F-ICBT
5.94
± 5.06
T1: Post-intervention 1
Group
Value
95% CI
R-ICBT
3.75
± 3.7
F-ICBT
4.59
± 4.01
T2: Post-intervention 2 (both completed full ICBT)
Group
Value
95% CI
R-ICBT
4.71
± 4.32
F-ICBT
4.59
± 4.01
T3: 2-month post-intervention
Group
Value
95% CI
R-ICBT
4.65
± 3.59
F-ICBT
3.13
± 2.36
Tinnitus and Hearing Survey (THS) - Sound Tolerance Sub-scale; Measure of Sound ToleranceSecondary· T0: Baseline, T1: Post-intervention 1 (after both group complete initial intervention), T2: Post-intervention 2 (after R-ICBT group complete Full ICBT), T3: 2-months post-intervention
Tinnitus and Hearing Survey (THS) is a 10-item questionnaire that helps in determining how much of a patient's complaint about tinnitus is due to a hearing problem and how much is due specifically to the tinnitus. THS has three sections/subscales (A, B, and C). Section A consists of four items that address common tinnitus problems. Section B contains four items that address hearing. Section C, which includes two items, which focus on sound tolerance problem and ability to participate in group therapy. Responses for each item can range from 0 (not a problem) to 4 (very big problem). The total T
T0: Baseline
Group
Value
95% CI
R-ICBT
1.17
± 1.4
F-ICBT
1.22
± 1.3
T1: Post-intervention 1
Group
Value
95% CI
R-ICBT
1.0
± 1.39
F-ICBT
0.67
± 1.07
T2: Post-intervention 2 (both completed full ICBT)
Group
Value
95% CI
R-ICBT
.96
± 1.3
F-ICBT
.67
± 1.07
T3: 2-month post-intervention
Group
Value
95% CI
R-ICBT
0.91
± 1.08
F-ICBT
0.47
± 0.74
Sponsor's own description
Nearly 50 million people in the U.S. experience tinnitus, of which about 20 million people have burdensome chronic tinnitus. Tinnitus can be very debilitating as many aspects of daily life can be affected, such as sleep, mood, and concentration. Currently, there is no cure for tinnitus. Pharmacological or sound-therapy based interventions are sometimes provided but may be of limited value to certain individuals. Research suggests that Cognitive Behavior Therapy (CBT) based approaches have the most evidence of effectiveness in the management of tinnitus. However, CBT is rarely offered to tinnitus sufferers in the U.S. (less than 1%), partly because of lack of trained professionals who can deliver CBT. To improve access to CBT for tinnitus, an online CBT program has been developed. The purpose of this study is to evaluate if the full CBT administered via the Internet results in better outcomes when compared to relaxation only CBT administered via the Internet for adults with tinnitus in the United States.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lamar University
Last refreshed: 16 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04335812.